Importantly, the mechanism of compensatory DNA replication signaling in tumor evolution and combined DNA metabolic cytotoxicity extend and unify promising treatment strategies that may improve DNA-PKcs-mutant glioma clinical therapy. The gene discussed is PRKDC; the disease is central nervous system cancer.